Obesity negatively impacts maintenance of antibody response to COVID-19 vaccines

Severe obesity accelerates the decline of neutralizing antibodies to COVID-19 vaccines contributing to increased risk of hospitalization from breakthrough SARS-CoV-2 infections.(1) These findings have repercussion on the vaccination policy for SARS-CoV-2 variants and other infectious diseases like i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauvin, Camille, Retnakumar, Sruthi Vijaya, Bayry, Jagadeesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Spotlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394250/
https://www.ncbi.nlm.nih.gov/pubmed/37467723
http://dx.doi.org/10.1016/j.xcrm.2023.101117
Descripción
Sumario:Severe obesity accelerates the decline of neutralizing antibodies to COVID-19 vaccines contributing to increased risk of hospitalization from breakthrough SARS-CoV-2 infections.(1) These findings have repercussion on the vaccination policy for SARS-CoV-2 variants and other infectious diseases like influenza in obese population.

Ejemplares similares